financetom
Business
financetom
/
Business
/
AbbVie Closes Bretisilocin Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AbbVie Closes Bretisilocin Acquisition
Oct 17, 2025 6:43 AM

09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin.

Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
National Bank Lifts Intact Financial Target to $280 After Q2
National Bank Lifts Intact Financial Target to $280 After Q2
Aug 1, 2024
11:31 AM EDT, 08/01/2024 (MT Newswires) -- National Bank has raised its one year target on Intact Financial ( IFCZF ) to $280, from $265, and maintained its Outperform rating after the company reported its second quarter results. We view the results as positive given the excellent underwriting performance across the business. IFC demonstrated underwriting strength through the 5%-point combined...
Sabre Shares Fall Despite Narrower Q2 Adjusted Loss, Higher Revenue
Sabre Shares Fall Despite Narrower Q2 Adjusted Loss, Higher Revenue
Aug 1, 2024
11:29 AM EDT, 08/01/2024 (MT Newswires) -- Sabre (SABR) shares retreated over 2% in recent Thursday trading despite posting a narrower Q2 adjusted loss and higher revenue that also topped analysts' expectations. The company posted a Q2 adjusted loss of $0.05 per share, narrowing from a loss of $0.17 a year earlier. Four analysts polled by Capital IQ expected a...
CRA International Shares Drop Despite Fiscal Q2 Beat, Updated 2024 Revenue Outlook
CRA International Shares Drop Despite Fiscal Q2 Beat, Updated 2024 Revenue Outlook
Aug 1, 2024
11:33 AM EDT, 08/01/2024 (MT Newswires) -- CRA International ( CRAI ) shares were down by nearly 12% in recent Thursday trading even as the company reported better-than-expected fiscal Q2 results and updated its full-year revenue guidance. Fiscal Q2 non-GAAP earnings were $1.83 per diluted share, up from $1.42 per share a year earlier, the company said. Three analysts polled...
Ecovyst Shares Plunge After Q2 Results Fall, 2024 Sales Guidance Cut
Ecovyst Shares Plunge After Q2 Results Fall, 2024 Sales Guidance Cut
Aug 1, 2024
11:29 AM EDT, 08/01/2024 (MT Newswires) -- Ecovyst ( ECVT ) shares were down more than 13% in recent Thursday trading after the company reported declines in Q2 adjusted earnings and sales and cut its full-year 2024 sales outlook. The company posted earlier Q2 adjusted earnings of $0.12 per diluted share, down from $0.29 a year earlier. Analysts polled by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved